COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials
The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candidate was found to be successful with respect to safety and immunogenicity, sources said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Clinical Trials | COVID-19 | Pharmaceuticals | Vaccines | Veterinary Vaccinations